Project Grant R21AI202473
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of North Carolina at Chapel Hill a Project Grant of $115,123.00 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on August 20, 2025, with a completion date of July 31, 2027. This research project, titled "Inside Out: Revealing Strategies for Intracellular S. Aureus Persister Eradication," addresses the critical challenge of antibiotic-tolerant...
- Federal Grant Award Summary The University of North Carolina at Chapel Hill received a $771,510 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded July 9, 2026, with completion targeted for June 30, 2031. The project addresses viral and host genetic determinants of La Crosse virus (LACV) neuroinvasive disease, the most common cause of pediatric arboviral encephalitis in the...
- Federal Project Grant Award Summary North Carolina State University received a $223,754 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded May 11, 2026, with completion targeted for April 30, 2028. The award funds research into posttranscriptional regulation of allergic inflammation, specifically investigating the role of tristetraprolin (TTP) in allergen-induced respiratory...
- Federal Grant Award Summary The University of North Carolina at Chapel Hill received a $421,067 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded on August 8, 2025, with a completion date of July 31, 2027. This research initiative delivers scientific investigation and experimental research services focused on understanding the mechanisms by which neutrophil extracellular traps...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of North Carolina at Charlotte $413,542 under the Allergy and Infectious Diseases Research program (CFDA 93.855) for a project grant commencing August 1, 2025, and concluding July 31, 2027. This exploratory and developmental R21 project focuses on developing novel therapeutic interventions targeting glial cells (astrocytes and microglia) to address central nervous system (CNS)...
- Federal Project Grant Award Summary North Carolina State University received a $418,000 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective August 1, 2025 through July 31, 2027. This exploratory research project investigates the causal relationships between cockroach infestations and indoor environmental biocontaminants in low-income households. The research will elucidate how...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of North Carolina at Chapel Hill a $211,073 Project Grant (CFDA 93.855—Allergy and Infectious Diseases Research) on April 20, 2026, with completion scheduled for March 31, 2028. The project develops genomic resources to identify the genetic basis of insecticide resistance in Lutzomyia sandflies, which are the primary vectors of Leishmania parasites in the Neotropics. With over 350...
- Federal Project Grant Award Summary The University of North Carolina at Chapel Hill received a $741,051 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded July 1, 2026, with completion targeted for June 30, 2031. The research project, titled "From Tolerance to Resistance: Adaptive Pathways of Enterobacterales Persistence in the Gut Under Antibiotic Pressure," investigates...
- Federal Project Grant Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of North Carolina at Chapel Hill $420,553 under the Allergy and Infectious Diseases Research program (CFDA 93.855) to develop novel single-cell measurement technologies and conduct fundamental research on antibiotic tolerance in bacterial populations. The award, effective August 8, 2025 through July 31, 2027, funds the design and implementation of a single-cell technique capable...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of North Carolina at Chapel Hill a Project Grant of $466,500 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on September 1, 2025, with a completion date of August 31, 2030. This research initiative will investigate the bacterial genetic basis of Mycobacterium tuberculosis (MTB) transmissibility through a population genomics-guided approach. The project...
North Carolina State University received a $239,429 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded July 14, 2026, with completion targeted for June 30, 2028. The project focuses on cultivation, genomic characterization, and virulence assessment of U.S. Orientia species, the bacterium responsible for scrub typhus. This research addresses the emerging public health threat posed by chigger-transmitted pathogens in the United States, an area previously assumed to pose minimal risk but recently identified as a potential disease vector following preliminary findings in North Carolina. The project deliverables include functional and genomic characterization of U.S. Orientia strains through two primary objectives: (1) assessment of transmissibility and virulence through species identification and in vitro functional assays, and (2) genomic evaluation of virulence factors in U.S. Orientia isolates. These outputs are intended to establish the foundation for development of public health diagnostics and enhance understanding of chigger-related disease transmission risk in the United States. The high-risk, high-reward research will provide critical baseline data on a pathogen affecting nearly a billion people globally and represents the first comprehensive functional and genomic analysis of U.S. Orientia strains.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $239.4k | 7/14/26 |